Immunoassays

AMA-M2-M is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgM antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).

AMA-M2-Check is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG and IgM antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).

beta2-Microglobulin is a solid phase enzyme immunoassay employing highly purified antihuman-beta-2-Microglobulin antibodies for the quantitative detection of beta-2-Microglobulin in human serum, plasma and urine.

Borrelia-G is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.

Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.

COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.

This protocol details the procedure for testing samples with the OLM Aspergillus LFD (AspLFD). The following protocol is summarised in the figure overleaf. Please see the AspLFD handbook for more detailed product information.

Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum.